Nuclear magnetic resonance imaging of experimentally induced liver disease.
about
Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change.In vivo proton nuclear magnetic resonance imaging and spectroscopy studies of halocarbon-induced liver damage.Measurement of fat/water ratios in rat liver using 3D three-point dixon MRI.Ferritin-induced relaxation in tissues: an in vitro study.Controlled aggregation of ferritin to modulate MRI relaxivity.In vivo NMR, biochemical, and histologic evaluation of alcohol-induced fatty liver in rat and a comparison with CCl4 hepatotoxicity.Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseasesMagnetic resonance imaging: present and future applications.A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique.Chronic carbon tetrachloride and phospholipase D hepatotoxicity in rat: in vivo 1H magnetic resonance, total lipid analysis, and histology.Estimating tissue iron burden: current status and future prospects.MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patientsRelaxation induced by ferritin: a better understanding for an improved MRI iron quantification.Magnetic resonance imaging quantification of liver iron.Is the magnetic resonance imaging proton spin-lattice relaxation time a reliable noninvasive parameter of developing liver fibrosis?Magnetic field dependence of solvent proton relaxation in aqueous solutions of Fe3+ complexes.Detection of liver fibrosis with magnetic cross-relaxation.T1 and T2 of ferritin solutions: effect of loading factor.Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths.Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial.The ferritin superfamily: Supramolecular templates for materials synthesis.Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls.Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia.Nuclear magnetic resonance of the liver, spleen, and pancreas.Variable-field relaxometry of iron-containing human tissues: a preliminary study.Mimicking liver iron overload using liposomal ferritin preparationsHepatitis, cirrhosis, and hepatoma.Hepatic Iron Quantification on 3 Tesla (3 T) Magnetic Resonance (MR): Technical Challenges and Solutions.Liver iron quantification by 3 tesla MRI: calibration on a rabbit model.R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.The role of diffusion-weighted imaging in prediction liver iron concentration in beta-thalassaemia patients.Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis.A modified saturation-recovery approximation for multiple spin-echo pulse sequences.Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo
P2860
Q30616960-FB278103-C3BE-47C8-AA27-CB83E84708A4Q30655457-482A5BE0-6EC7-4BEF-B029-3CF254B6AEB4Q30870806-8774180B-3E63-4F42-AE11-E980895B97AFQ30919468-C3B54654-B587-455A-8348-C8E6968FB787Q30962818-838901C7-2EC8-4B0B-9D13-44E46FFF8B1CQ31149022-E7F16235-8322-4350-AC65-27FA654F209AQ33577196-37B202F0-368C-4C24-89B8-B3FA0F545013Q33909042-C421A92C-97C7-418D-B575-5BA647EA08E0Q34299061-922085EE-366C-4673-8B26-0C1FEDC9764EQ34568446-9BEA0E21-B739-4913-91AE-6E78AAD9A6DBQ34900043-FF899067-2708-4E2B-A82D-A77D7B204C26Q35793545-D481BF2D-AE53-4961-AE87-8D26A26C9D80Q35848072-410D5107-10E7-49F0-8ADC-2C0CF3DD1464Q35939117-2FE763CA-019B-42AC-B216-4610217BBD4CQ36197679-20B991E7-D299-45FB-ACC7-2E96AB536837Q36450535-443BF39A-A40F-4707-BCEB-B8A502644243Q36491980-9EA0B9A4-37FA-47E5-BDA8-980C3CBEDAB2Q36732478-66FA1F91-99DB-413E-BA89-D853464C3A9BQ36818291-B1FDB021-CD64-48F5-9210-20156DC4E1DFQ36852781-9EFBBA7E-16D3-4E09-AE5F-2F9A24025804Q37305834-8CEE89ED-7CA9-4B9B-B064-A20E32C31934Q37660707-2903057B-3FBD-4EAA-A2AB-15ABC2C32841Q37801556-DC68808E-0997-466A-BA0D-94DB0BE1432FQ38435433-1C49EAE8-A6C2-4FA2-B34B-FD85FAA7F1EAQ39274361-A34A54F5-2A2E-4070-9353-954F526FA795Q39500968-1DBB345B-CDF3-431D-A6AB-6229B4DD709AQ39966094-185B9802-77BF-453B-AB1A-6BC514588F4AQ41492944-19F83F06-033F-4272-B6E8-6C4C7C75AE60Q41751285-8B08327B-A52C-470C-9FE0-B299B1CBF3A5Q41814500-E7C55619-8165-47B9-9422-EBD670635CDDQ46055972-D95323F4-2DD1-47E5-A90B-2CA0EF8DCA5BQ46865825-2299B95F-6F93-49BB-9830-507C447B3454Q48146955-11F36B80-919D-46E7-BB8F-D6DE565D3DFBQ48787004-CFBA85BB-D384-4206-B523-328FA4FA6267Q52390993-06C0D2EB-C788-4372-98C1-58B55FC321E2Q52647245-F17A506E-EED6-49F0-884D-61AD55FDB0FBQ57186714-18B6DC5F-6353-4F35-9BBA-F45E7E1404BD
P2860
Nuclear magnetic resonance imaging of experimentally induced liver disease.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@ast
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@en
type
label
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@ast
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@en
prefLabel
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@ast
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@en
P2093
P1433
P1476
Nuclear magnetic resonance imaging of experimentally induced liver disease.
@en
P2093
H I Goldberg
J H McKerrow
P304
P356
10.1148/RADIOLOGY.148.3.6192464
P407
P577
1983-09-01T00:00:00Z